| http://www.w3.org/ns/prov#value | - Ventrus Biosciences, Inc. (Nasdaq: VTUS) 8% LOWER; is concurrently offering to sell, subject to market and other conditions, (i) shares of its common stock in an underwritten public offering, and (ii) shares of its Series A Convertible Preferred Stock in a separate underwritten public offering.
|
